GLP-1s in 2026: Fund Access, Protect Outcomes, Avoid the Blank Check

If you manage employer benefits, you’re staring at a 2026 puzzle: demand for GLP-1 medications keeps climbing while prices remain elevated, and oral options may expand utilization further. The question isn’t whether to support people who could benefit. The question is how to do it responsibly for members and the plan. The solution is not blanket exclusion – it is structured access with accountability and a defined step-down plan that ensures results are durable, not open-ended.

  • 2 Min read

  • October 27, 2025

Nicole Hancy

Nicole Hancy

PharmD
Best Practices
GLP-1 Cost Strategy 2026

Why the Pressure is Rising

Independent modeling shows that covering GLP-1s without strong controls can push employer premiums materially higher; scenarios using current real-world costs show increases in the mid-single to low-teens, while a low-price $200/month scenario drops the impact closer to ~1–4%.1 That spread underscores how plan design, adherence, and net cost control drive affordability.

At the same time, employer surveys point to sustained cost headwinds: prescription spend rose ~8% in 2024, and 77% of large employers say managing GLP-1 costs is a top pharmacy priority heading into 2026. 2

What Not To Do

Two extreme strategies tend to backfire:

  • Open-ended coverage that fuels rapid cost growth and high early drop-off.
  • Blanket exclusions push members to cash-pay/DTC channels and raise equity and safety concerns.

Neither approach builds trust with employees or meets Finance’s need for predictable cost trend.

A Better Path: Structured Access With Accountability

A durable GLP-1 strategy has four parts:

  1. Appropriateness first. Prior authorization grounded in clinical guidance and your population. Define who qualifies, when to start, and what must be ruled out or tried first.
  2. Step therapy with clinical logic. Sequence within and across classes with clear clinical rationale and an exception path so it preserves choice rather than feels restrictive.
  3. Human coaching to prevent early drop-off. The first 3–6 months are where many members struggle most. Nurse/pharmacist support, nutrition guidance, and connected tracking improve adherence and make outcomes stick—moving from “access” to true impact.
  4. A defined step-down plan. Set expectations before approval. Many employers are adopting 12–18 month models with reassessments so members maintain health gains rather than drift into lifetime drug dependence.

Proof in practice: Programs built this way have delivered ~15% average weight loss over 18 months, 40% adherence boost, 90% member-reported better health, and up to 54% medication savings.

GLP-1 webinar banner | LucyRx

What Finance Needs To See

Premium risk isn’t just how many people start GLP-1s. It’s how long they stay on therapy, whether dose-escalation is controlled, and what the plan actually pays (net cost). Modeling shows a wide premium-impact range depending on those inputs; adherence support, utilization management, and competitive sourcing can narrow the range for your plan. Report quarterly on: adherence, early drop-off, adverse events, coaching intervention rates, step-down progression vs. stalled escalations, and net cost per 1,000—and tie each metric to a pre-agreed action.

Planning For Oral Options and 2026 Dynamics

Expect oral GLP-1s to draw in members who avoided injections. Now is the moment to update PA and step therapy, educate on side effects and behavior change, and keep the step-down strategy front-and-center so prescribers and members what happens next before treatment begins.

What To Do Next

Get the GLP-1 Planning Checklist — A practical, HR-ready tool covering seven critical levers: appropriateness criteria, step therapy, continuation rules, coaching, behavioral health, menopause pathways, and sourcing—so you can enable access without writing a blank check.

Get the Interactive Checklist

Footnotes
[1] Employee Benefit Research Institute (EBRI). GLP-1 Coverage and Its Impact on Employment-Based Health Plan Premiums: A Simulation-Based Analysis. Oct 9, 2025.
[2] Mercer. Survey on Health & Benefit Strategies for 2026.

Tags

GLP-1 Weight loss management

Recommended Reads

doctor writing a prescription

PBM Reform Update: What the CAA and DOL Proposal Mean for Plan Sponsors

With the Consolidated Appropriations Act of 2026 and a Department of Labor proposal focused on PBM disclosures, employers are seeing more headlines and asking sharper questions about how their pharmacy benefits are structured.
woman and doctor

Making Menopause Support Real: What Employers Are Asking and How We Help

Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
woman talking

Menopause Is a Workforce Issue. Your Pharmacy Benefit Should Treat It That Way.

Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.
Menopause benefits

Menopause Benefits: From Nice-to-Have to Business Imperative

Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Woman and Pharmacist

Why “Affordability” Became the Word of the Moment — and What Healthcare Misses

Healthcare affordability is not just about price. Learn what patients experience at the pharmacy counter and why unpredictability erodes trust.
Connected Specialty Care Network + Care Guides

The Difference Between Access on Paper and Access in Practice

Understand why specialty drug access breaks down after coverage is approved and how employers can close the gap between coverage and care.
Woman receiving a prescription

Behind Every Claim Is a Person: Why Prescription Care Needs a Different Playbook in 2026

If you spend your days looking at pharmacy trend reports and renewal spreadsheets, it is easy to forget what those numbers really represent.
employees talking to each other

The Hidden Driver of Employee Experience (and Retention): Human-Led Care Guides

Human-led Care Guides reduce friction in complex medication moments, helping employees start and stay on therapy. The result: better experience, higher confidence, and stronger retention for employers.
doctor and patient

The Yardstick That Matters: Redefining Outcomes in Prescription Care

Outcomes don’t improve by accident. Better processes, faster therapy access, and clear guidance are the foundation of patient-centered prescription care—and the new standard employers should expect.
formulary design that captures savings

Formulary design that captures the savings (without disruption)

Rebates don’t equal value. Here’s how to align to net cost, enable substitution, and keep your people on track.
PreviousNext
doctor writing a prescription

PBM Reform Update: What the CAA and DOL Proposal Mean for Plan Sponsors

With the Consolidated Appropriations Act of 2026 and a Department of Labor proposal focused on PBM disclosures, employers are seeing more headlines and asking sharper questions about how their pharmacy benefits are structured.
woman and doctor

Making Menopause Support Real: What Employers Are Asking and How We Help

Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
woman talking

Menopause Is a Workforce Issue. Your Pharmacy Benefit Should Treat It That Way.

Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.
Menopause benefits

Menopause Benefits: From Nice-to-Have to Business Imperative

Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Woman and Pharmacist

Why “Affordability” Became the Word of the Moment — and What Healthcare Misses

Healthcare affordability is not just about price. Learn what patients experience at the pharmacy counter and why unpredictability erodes trust.
Connected Specialty Care Network + Care Guides

The Difference Between Access on Paper and Access in Practice

Understand why specialty drug access breaks down after coverage is approved and how employers can close the gap between coverage and care.
Woman receiving a prescription

Behind Every Claim Is a Person: Why Prescription Care Needs a Different Playbook in 2026

If you spend your days looking at pharmacy trend reports and renewal spreadsheets, it is easy to forget what those numbers really represent.
employees talking to each other

The Hidden Driver of Employee Experience (and Retention): Human-Led Care Guides

Human-led Care Guides reduce friction in complex medication moments, helping employees start and stay on therapy. The result: better experience, higher confidence, and stronger retention for employers.
doctor and patient

The Yardstick That Matters: Redefining Outcomes in Prescription Care

Outcomes don’t improve by accident. Better processes, faster therapy access, and clear guidance are the foundation of patient-centered prescription care—and the new standard employers should expect.
PreviousNext

LucyRx is a fast-scaling, independent, next-generation pharmacy benefit manager (PBM) redefining prescription care for plan sponsors and members nationwide.

Follow us

Linkedin Linkedin Tiktok Tiktok Instagram Instagram

Copyright © 2026 by LucyRx. All Rights Reserved | Privacy Policy | Terms of Use | Members Rights

The Silent Surge Driving Pharmacy Costs — and How to Stop ItThe Silent Surge Driving Pharmacy Costs — and How to Stop ItGLP-1 Planning ChecklistGLP-1 Planning Checklist

Download the PBM Reform Readiness Checklist

Download the GLP-1 Planning Checklist